CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Acupuncturedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03170648
NCT03170648N/ACompleted

Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study

Dana-Farber Cancer Institute·interventional·Posted May 31, 2017·Updated Apr 30, 2025

In Brief

A clinical study evaluating Acupuncture for Breast Cancer. Completed, enrolled 26 participants across 1 site.

Detailed Summary

This research study is evaluating ear acupuncture as a possible treatment to reduce symptoms related to receiving chemotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 31, 2017
Enrollment StartJun 19, 2017
Primary CompletionDec 31, 2022
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 9.1 years ago

Interventions

Acupuncturedevice

Acupuncture has been studied in clinical trials in cancer patients and has been shown to be helpful for management of pain, nerve damage from chemotherapy, and nausea